Advisors Preferred LLC Purchases Shares of 588 Becton Dickinson and Co (BDX)

Advisors Preferred LLC purchased a new stake in Becton Dickinson and Co (NYSE:BDX) in the 4th quarter, Holdings Channel reports. The fund purchased 588 shares of the medical instruments supplier’s stock, valued at approximately $126,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Quadrant Capital Group LLC increased its stake in Becton Dickinson and by 0.5% in the second quarter. Quadrant Capital Group LLC now owns 9,960 shares of the medical instruments supplier’s stock valued at $1,925,000 after purchasing an additional 45 shares in the last quarter. WFG Advisors LP increased its stake in Becton Dickinson and by 0.9% in the second quarter. WFG Advisors LP now owns 5,376 shares of the medical instruments supplier’s stock valued at $1,049,000 after purchasing an additional 48 shares in the last quarter. Coldstream Capital Management Inc. increased its stake in Becton Dickinson and by 9.1% in the second quarter. Coldstream Capital Management Inc. now owns 2,104 shares of the medical instruments supplier’s stock valued at $411,000 after purchasing an additional 175 shares in the last quarter. Wendell David Associates Inc. increased its stake in Becton Dickinson and by 1.3% in the fourth quarter. Wendell David Associates Inc. now owns 17,107 shares of the medical instruments supplier’s stock valued at $3,662,000 after purchasing an additional 225 shares in the last quarter. Finally, Pacer Advisors Inc. increased its stake in Becton Dickinson and by 4.9% in the third quarter. Pacer Advisors Inc. now owns 5,043 shares of the medical instruments supplier’s stock valued at $988,000 after purchasing an additional 234 shares in the last quarter. 77.50% of the stock is owned by hedge funds and other institutional investors.

In other Becton Dickinson and news, Director Timothy M. Ring sold 269,661 shares of the company’s stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $217.82, for a total value of $58,737,559.02. Following the completion of the sale, the director now directly owns 295,753 shares of the company’s stock, valued at approximately $64,420,918.46. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.00% of the company’s stock.

Shares of Becton Dickinson and Co (NYSE BDX) opened at $218.32 on Friday. Becton Dickinson and Co has a 52-week low of $175.66 and a 52-week high of $248.39. The company has a debt-to-equity ratio of 1.04, a current ratio of 1.54 and a quick ratio of 0.93. The stock has a market cap of $58,130.00, a PE ratio of 1,559.43, a price-to-earnings-growth ratio of 1.57 and a beta of 1.12.

Becton Dickinson and (NYSE:BDX) last issued its quarterly earnings data on Tuesday, February 6th. The medical instruments supplier reported $2.48 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.41 by $0.07. Becton Dickinson and had a net margin of 2.71% and a return on equity of 16.19%. The business had revenue of $3.08 billion during the quarter, compared to the consensus estimate of $3.05 billion. During the same period in the prior year, the firm posted $2.33 EPS. The firm’s quarterly revenue was up 5.4% compared to the same quarter last year. equities analysts predict that Becton Dickinson and Co will post 10.94 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 30th. Shareholders of record on Friday, March 9th will be given a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a yield of 1.37%. The ex-dividend date is Thursday, March 8th. Becton Dickinson and’s payout ratio is 2,142.86%.

Several equities research analysts have weighed in on BDX shares. Argus lifted their price target on shares of Becton Dickinson and to $235.00 and gave the company a “buy” rating in a research note on Thursday, December 14th. They noted that the move was a valuation call. KeyCorp initiated coverage on shares of Becton Dickinson and in a research report on Friday, January 5th. They set an “overweight” rating and a $260.00 target price for the company. Bank of America reissued a “buy” rating and set a $260.00 target price on shares of Becton Dickinson and in a research report on Friday, January 19th. Morgan Stanley boosted their target price on shares of Becton Dickinson and from $205.00 to $245.00 and gave the stock an “equal weight” rating in a research report on Friday, November 3rd. Finally, Royal Bank of Canada reissued a “sector perform” rating and set a $230.00 target price (up from $210.00) on shares of Becton Dickinson and in a research report on Friday, November 3rd. Four investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $237.27.

ILLEGAL ACTIVITY NOTICE: “Advisors Preferred LLC Purchases Shares of 588 Becton Dickinson and Co (BDX)” was posted by BBNS and is owned by of BBNS. If you are reading this news story on another site, it was stolen and reposted in violation of US and international copyright and trademark laws. The original version of this news story can be viewed at https://baseballnewssource.com/markets/advisors-preferred-llc-purchases-shares-of-588-becton-dickinson-and-co-bdx/1907293.html.

Becton Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton Dickinson and Co (NYSE:BDX).

Institutional Ownership by Quarter for Becton Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Red Sox: J.D. Martinez Continues His Physical at Spring Training Facility
Red Sox: J.D. Martinez Continues His Physical at Spring Training Facility
Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Cubs Sign Free Agent Yu Darvish
Cubs Sign Free Agent Yu Darvish


Leave a Reply

 
© 2006-2018 BBNS.